tiprankstipranks
Trending News
More News >
NexgenRx Inc (TSE:NXG)
:NXG
Canadian Market

NexgenRx (NXG) Financial Statements

Compare
18 Followers

NexgenRx Financial Overview

NexgenRx's market cap is currently C$24.18M. The company's EPS TTM is C$0.008; its P/E ratio is 21.12; NexgenRx is scheduled to report earnings on November 21, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit$ 10.82M-$ 9.81M$ 9.67M$ 8.37M
Operating Income$ -143.88K-$ 2.20M$ 2.16M$ 93.52K
EBITDA$ 1.15M-$ 3.40M$ 2.96M$ 815.97K
Net Income$ -331.97K-$ 4.02M$ 2.12M$ -207.94K
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 30.20M$ 25.75M$ 29.44M$ 25.24M$ 21.19M
Total Debt$ 461.88K$ 432.47K$ 401.76K$ 1.45M$ 4.10M
Net Debt$ -1.41M$ -1.33M$ -1.92M$ 643.66K$ 3.57M
Total Liabilities$ 22.48M$ 16.90M$ 19.72M$ 19.72M$ 19.35M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ 1.03M-$ 2.45M$ 2.65M$ 1.05M
Operating Cash Flow$ 1.28M$ 1.07M$ 3.82M$ 2.65M$ 1.05M
Investing Cash Flow
Financing Cash Flow
Currency in USD

NexgenRx Earnings and Revenue History

NexgenRx Debt to Assets

NexgenRx Cash Flow

NexgenRx Forecast EPS vs Actual EPS